HPGC Renmintongtai Pharmaceutical Corporation Sustainability Profile
HPGC Renmintongtai Pharmaceutical Corporation, headquartered in China (CN), is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of innovative healthcare solutions. Founded in the early 2000s, the company has achieved significant milestones, establishing a strong presence in both domestic and international markets. With a focus on traditional Chinese medicine and modern pharmaceutical products, HPGC Renmintongtai offers a diverse range of core services, including herbal formulations and advanced therapeutic agents. Their commitment to quality and efficacy sets them apart in a competitive landscape. Recognised for their contributions to healthcare, the corporation has garnered a reputation for excellence, positioning itself as a leader in the industry.
DitchCarbon Score
How does HPGC Renmintongtai Pharmaceutical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HPGC Renmintongtai Pharmaceutical Corporation's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HPGC Renmintongtai Pharmaceutical Corporation's reported carbon emissions
HPGC Renmintongtai Pharmaceutical Corporation, headquartered in China, currently does not report any specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, HPGC Renmintongtai Pharmaceutical Corporation has not established any documented reduction targets or initiatives. The company does not appear to be part of any significant climate pledges or frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As there is no available data on emissions or reduction initiatives, it is unclear how HPGC Renmintongtai Pharmaceutical Corporation is addressing its carbon footprint or contributing to broader climate action efforts within the pharmaceutical industry.
How Carbon Intensive is HPGC Renmintongtai Pharmaceutical Corporation's Industry?
How Carbon Intensive is HPGC Renmintongtai Pharmaceutical Corporation's Location?
HPGC Renmintongtai Pharmaceutical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
HPGC Renmintongtai Pharmaceutical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
